Long-Term Atogepant Effective, Safe as Migraine Preventive, Open-Label Studies Show; Results showed consistent reductions in monthly migraine days over 48 weeks, with a favorable safety profile observed.

  • Sait Ashina

Press/Media

Period15 Apr 2024

Media coverage

1

Media coverage

  • TitleLong-Term Atogepant Effective, Safe as Migraine Preventive, Open-Label Studies Show; Results showed consistent reductions in monthly migraine days over 48 weeks, with a favorable safety profile observed.
    Media name/outletNeurology Live
    Country/TerritoryUnited States
    Date15/04/24
    PersonsSait Ashina
View all 1
View less